NGFR產(chǎn)品信息
英文名稱:Low affinity neurotrophin receptor p75NTR
中文名稱:低親和力神經(jīng)營養(yǎng)因子受體p75NTR
靶點(diǎn)別稱:NGFR,TNFRSF16
物種:Human
標(biāo)簽:Fc Tag
屬性:Protein,Cell
標(biāo)記:Unconjugated
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human NGFR Protein, Fc Tag (NGR-H5254) is expressed from human 293 cells (HEK293). It contains AA Lys 29 - Asn 250 (Accession # P08138-1).
Predicted N-terminus: Lys 29
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a human IgG1 Fc tag at the C-terminus
The protein has a calculated MW of 50.0 kDa. The protein migrates as 60-65 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
p75神經(jīng)營養(yǎng)因子受體(p75NTR)最初被鑒定為神經(jīng)營養(yǎng)因子(NGF R)的低親和力受體。神經(jīng)營養(yǎng)因子受體結(jié)合神經(jīng)營養(yǎng)因子,包括神經(jīng)生長因子、神經(jīng)營養(yǎng)因子-3、腦源性神經(jīng)營養(yǎng)因子和神經(jīng)營養(yǎng)因子-4。所有神經(jīng)營養(yǎng)因子都與p75NTR結(jié)合。這也包括未成熟的促神經(jīng)營養(yǎng)因子形式。神經(jīng)營養(yǎng)因子受體,包括p75NTR,負(fù)責(zé)確保發(fā)育中神經(jīng)元的適當(dāng)密度與靶比,將發(fā)育中更廣泛的圖譜細(xì)化為精確的連接。p75NTR參與促進(jìn)神經(jīng)元存活和神經(jīng)元死亡的途徑。
關(guān)鍵字: NGFR;NGFR蛋白;TNFRSF16;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。